Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis-Reference-Cited by-同舟云学术

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis

Published:2022-03-12 Issue:2 Volume:41 Page:169-180
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Namisaki Tadashi^ORCID,Kaji Kosuke,Shimozato Naotaka,Kaya Daisuke,Ozutsumi Takahiro,Tsuji Yuki,Fujinaga Yukihisa,Kitagawa Koh,Furukawa Masanori,Sato Shinya,Sawada Yasuhiko,Nishimura Norihisa,Takaya Hiroaki,Okura Yasushi,Seki Kenichiro,Kawaratani Hideto,Moriya Kei,Noguchi Ryuichi,Asada Kiyoshi,Akahane Takemi,Mitoro Akira,Yoshiji Hitoshi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s12664-021-01220-5.pdf

Reference47 articles.

1. Ogawa Y, Kobayashi T, Honda Y, et al. Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: a multicenter study. Hepatol Res. 2020;50:955–65.

2. Inadomi C, Takahashi H, Ogawa Y, et al. Accuracy of the enhanced liver fibrosis test, and combination of the enhanced liver fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Res. 2020;50:682–92.

3. Oeda S, Takahashi H, Imajo K, et al. Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: comparison between M and XL probes. Hepatol Res. 2020;50:831–9.

4. Eguchi Y, Wong G, Akhtar O, Sumida Y. Non-invasive diagnosis of non-alcoholic steatohepatitis and advanced fibrosis in Japan: a targeted literature review. Hepatol Res. 2020;50:645–55.

5. Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557–65.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway;Journal of Natural Medicines;2024-02-09

2. Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives;Biomedicines;2023-07-12

3. Obeticholic Acid—A Pharmacological and Clinical Review;Future Pharmacology;2023-02-28

4. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease;Pharmacological Research;2022-11

5. Editorial commentary on the Indian Journal of Gastroenterology—March–April 2022;Indian Journal of Gastroenterology;2022-04